Use of Flt3 Ligand for Strengthening Immune Responses in Rna Immunization

The invention relates to supplying vaccine RNA to cells. The invention relates in particular to a common use of vaccine RNA and Flt3 ligand for inducing, creating or enhancing an immune response when administered to animals (including humans).

Attached files:
2010066418.jpg

Patents:
WO 2,010,066,418   [MORE INFO]

Inventor(s): SAHIN UGUR [DE]; TUERECI OEZLEM [DE]; KREITER SEBASTIAN [DE]

Type of Offer: Sale



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent